3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione

C16H28N2O3 — CID 103141854

IUPAC3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
SMILESCCC(C)C1NC(=O)C(CC)N(CC2CCC(C)O2)C1=O
InChIInChI=1S/C16H28N2O3/c1-5-10(3)14-16(20)18(13(6-2)15(19)17-14)9-12-8-7-11(4)21-12/h10-14H,5-9H2,1-4H3,(H,17,19)
InChIKeyQGAMGYVTTXYLMD-UHFFFAOYSA-N
MW296.41 g/mol
LogP1.71
Rot. Bonds5

About 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione

3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione (PubChem CID 103141854) has the molecular formula C16H28N2O3 and a molecular weight of 296.41 g/mol. Its IUPAC name is 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione.

Molecular Properties

Compound Name3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
PubChem CID103141854
Molecular FormulaC16H28N2O3
Molecular Weight296.41 g/mol
Exact Mass296.21
IUPAC Name3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
SMILESCCC(C)C1NC(=O)C(CC)N(CC2CCC(C)O2)C1=O
InChIInChI=1S/C16H28N2O3/c1-5-10(3)14-16(20)18(13(6-2)15(19)17-14)9-12-8-7-11(4)21-12/h10-14H,5-9H2,1-4H3,(H,17,19)
InChIKeyQGAMGYVTTXYLMD-UHFFFAOYSA-N
XLogP1.71
TPSA58.64 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500296.41
LogP ≤ 51.71
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-butan-2-yl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
CID 103142001
6-butan-2-yl-3-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
CID 103141809
6-cyclopropyl-1-[(5-methyloxolan-2-yl)methyl]-3-propan-2-ylpiperazine-2,5-dione
CID 103141773
3-butan-2-yl-1-(oxolan-2-ylmethyl)-6-propylpiperazine-2,5-dione
CID 64902530
3-ethyl-1-[(5-methyloxolan-2-yl)methyl]-6-propan-2-ylpiperazine-2,5-dione
CID 103141807
6-ethyl-1-[(2-methylcyclopropyl)methyl]-3-propan-2-ylpiperazine-2,5-dione
CID 113464219
3-butan-2-yl-1-(2-butoxyethyl)-6-ethylpiperazine-2,5-dione
CID 64902153
3-butan-2-yl-1-(3-ethoxypropyl)-6-ethylpiperazine-2,5-dione
CID 64958605
3-butan-2-yl-1-[3-(dimethylamino)propyl]-6-ethylpiperazine-2,5-dione
CID 64960213
7-methyl-1-[(5-methyloxolan-2-yl)methyl]-3-propan-2-yl-1,4-diazepane-2,5-dione
CID 103142016
6-ethyl-1-[(3-methylcyclopentyl)methyl]-3-propan-2-ylpiperazine-2,5-dione
CID 107415616
6-ethyl-1-[(2-methylcyclohexyl)methyl]-3-propan-2-ylpiperazine-2,5-dione
CID 64967164

Frequently Asked Questions

What is the IUPAC name of 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione?
The IUPAC name of 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione (CID 103141854) is 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione.
What is the SMILES notation for 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione?
The canonical SMILES for 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione is CCC(C)C1NC(=O)C(CC)N(CC2CCC(C)O2)C1=O.
What is the InChIKey of 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione?
The InChIKey is QGAMGYVTTXYLMD-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H28N2O3/c1-5-10(3)14-16(20)18(13(6-2)15(19)17-14)9-12-8-7-11(4)21-12/h10-14H,5-9H2,1-4H3,(H,17,19).
What are the key properties of 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione?
3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione has a molecular weight of 296.41 g/mol, XLogP of 1.71, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 3-butan-2-yl-6-ethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione is sourced from PubChem (CID 103141854), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).